Announcements Trials
Browse Landscape

Status

Completed 108Recruiting 31Terminated 28Unknown 21Withdrawn 14Active not recruiting 12Not yet recruiting 4Available 3Approved for marketing 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Expanded_access 3

Sponsor

Cancer Type

CNS 3Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Neuroblastoma 6Glioblastoma 4Recurrence 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Stomach Neoplasms 2Pheochromocytoma 2Ovarian Neoplasms 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Paraganglioma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive 1Meningioma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

3-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × Recurrence × CNS × Clear all
NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

NCT03015844 2024-07-05

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Northwell Health

Available
CNSEndocrine

Neuroblastoma, Pheochromocytoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡